Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Wild

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Plos One|October 19, 2012
Localising loci underlying complex trait variation using Regional Genomic Relationship MappingYoshitaka Nagamine, Ricardo Pong-Wong, Pau Navarro, et al.
European Journal of Public Health|May 24, 2011
Mortality from circulatory diseases by specific country of birth across six European countries: test of conceptRaj S Bhopal, Snorri B Rafnsson, Charles Agyemang, et al.
Diabetes Care|June 26, 2020
Prescribing Paradigm Shift? Applying the 2019 European Society of Cardiology-Led Guidelines on Diabetes, Prediabetes, and Cardiovascular Disease to Assess Eligibility for Sodium-Glucose Cotransporter 2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists as First-Line Monotherapy (or Add-on to Metformin Monotherapy) in Type 2 Diabetes in ScotlandThomas M Caparrotta, Luke A K Blackbourn, Stuart J McGurnaghan, et al.
Diabetes, Obesity & Metabolism|June 24, 2025
Risk factors for development of diabetic foot ulcer disease in two large contemporary UK cohortsSafoora Gharibzadeh, Jiyoung Lee, Patrick Highton, et al.
Diabetes Research and Clinical Practice|August 3, 2021
REPRINT OF: CLASSIFICATION OF DIABETES MELLITUSAmanda Adler, Peter Bennett, Stephen Colagiuri Chair, et al.
BMJ Open|October 12, 2022
Cohort profile: the Scottish Diabetes Research Network national diabetes cohort - a population-based cohort of people with diabetes in ScotlandStuart J McGurnaghan, Luke A K Blackbourn, Thomas M Caparrotta, et al.
BMJ Open|October 27, 2022
Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocolElaine Butterly, Lili Wei, Amanda I Adler, et al.
Plos One|August 11, 2022
Large socioeconomic gap in period life expectancy and life years spent with complications of diabetes in the Scottish population with type 1 diabetes, 2013-2018Andreas Höhn, Stuart J McGurnaghan, Thomas M Caparrotta, et al.
European Journal of Preventive Cardiology|October 8, 2022
Estimating individual lifetime risk of incident cardiovascular events in adults with Type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2)Helena Bleken Østergaard, Steven H J Hageman, Stephanie H Read, et al.
JAMA|February 3, 2025
Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes: A Network Meta-AnalysisPeter Hanlon, Elaine Butterly, Lili Wei, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Plos One|October 19, 2012
Localising loci underlying complex trait variation using Regional Genomic Relationship MappingYoshitaka Nagamine, Ricardo Pong-Wong, Pau Navarro, et al.
European Journal of Public Health|May 24, 2011
Mortality from circulatory diseases by specific country of birth across six European countries: test of conceptRaj S Bhopal, Snorri B Rafnsson, Charles Agyemang, et al.
Diabetes Care|June 26, 2020
Prescribing Paradigm Shift? Applying the 2019 European Society of Cardiology-Led Guidelines on Diabetes, Prediabetes, and Cardiovascular Disease to Assess Eligibility for Sodium-Glucose Cotransporter 2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists as First-Line Monotherapy (or Add-on to Metformin Monotherapy) in Type 2 Diabetes in ScotlandThomas M Caparrotta, Luke A K Blackbourn, Stuart J McGurnaghan, et al.
Diabetes, Obesity & Metabolism|June 24, 2025
Risk factors for development of diabetic foot ulcer disease in two large contemporary UK cohortsSafoora Gharibzadeh, Jiyoung Lee, Patrick Highton, et al.
Diabetes Research and Clinical Practice|August 3, 2021
REPRINT OF: CLASSIFICATION OF DIABETES MELLITUSAmanda Adler, Peter Bennett, Stephen Colagiuri Chair, et al.
BMJ Open|October 12, 2022
Cohort profile: the Scottish Diabetes Research Network national diabetes cohort - a population-based cohort of people with diabetes in ScotlandStuart J McGurnaghan, Luke A K Blackbourn, Thomas M Caparrotta, et al.
BMJ Open|October 27, 2022
Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocolElaine Butterly, Lili Wei, Amanda I Adler, et al.
Plos One|August 11, 2022
Large socioeconomic gap in period life expectancy and life years spent with complications of diabetes in the Scottish population with type 1 diabetes, 2013-2018Andreas Höhn, Stuart J McGurnaghan, Thomas M Caparrotta, et al.
European Journal of Preventive Cardiology|October 8, 2022
Estimating individual lifetime risk of incident cardiovascular events in adults with Type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2)Helena Bleken Østergaard, Steven H J Hageman, Stephanie H Read, et al.
JAMA|February 3, 2025
Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes: A Network Meta-AnalysisPeter Hanlon, Elaine Butterly, Lili Wei, et al.
Pageof 14